Differential expression of ADAM10 in fetal membranes during pregnancy and evaluation as an early blood biomarker for preterm birth

Key Points

• Early detection of preterm birth may be possible through monitoring ADAM10 levels in fetal membranes.
• ADAM10 expression is differentially regulated during pregnancy, with implications for its role as a biomarker.
• Evidence indicates significant fluctuations of ADAM10 in the context of preterm birth risk, possibly aiding in diagnostics.
• Findings suggest that measuring ADAM10 levels could enhance preventive strategies for preterm birth.